Literature DB >> 3972403

Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.

J W Said, S Vimadalal, G Nash, I P Shintaku, R C Heusser, A F Sassoon, R V Lloyd.   

Abstract

Sixty-four lung tumors were evaluated for the presence of immunoreactive neuron-specific enolase (NSE), bombesin (Bn), and chromogranin (Cg) to assess their value as markers for neuroendocrine cells in the histologic diagnosis of pulmonary neoplasms. Staining was correlated with the presence and density of neurosecretory granules (number of neurosecretory granules per unit cytoplasmic cross-sectional area) as determined by planimetry on electron micrographs. The cytoplasmic density of neurosecretory granules was significantly greater in the carcinoid tumors than in the small cell carcinomas (P less than 0.001). Neuron-specific enolase was localized in all of the neuroendocrine granule-bearing tumors but was also present in 57 per cent of the nonneuroendocrine carcinomas. Bombesin was present in 68 per cent of the neuroendocrine tumors and in less than 1 per cent of the nonneuroendocrine tumors. Staining for Cg appeared to correlate with the density of neuroendocrine granules, with staining in carcinoid tumors but no staining in small cell anaplastic carcinomas. A panel of antibodies may be required for the reliable identification of neuroendocrine lung tumors by immunohistochemical techniques.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972403     DOI: 10.1016/s0046-8177(85)80008-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

2.  Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids.

Authors:  R Weiler; H Feichtinger; K W Schmid; R Fischer-Colbrie; L Grimelius; B Cedermark; M Papotti; G Bussolati; H Winkler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 3.  Neuroendocrine differentiation in lung carcinoma.

Authors:  B J Addis
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

Review 4.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

5.  Morphometric and flow cytometric analysis of small cell undifferentiated carcinoma of the bladder.

Authors:  C E Blomjous; W Vos; N W Schipper; H J De Voogt; J P Baak; C J Meijer
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

6.  Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.

Authors:  J R Gosney; M A Gosney; M Lye; S A Butt
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

7.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.

Authors:  Yasushi Tanaka; Toshiaki Sano; Zhi Rong Qian; Mitsuyoshi Hirokawa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

8.  Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.

Authors:  P O'Shea; M Cassidy; R Freaney; P McCarthy; J Fennelly
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

Review 9.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Tumour markers: An overview.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.